Analytical Data
-
基因名
AspF9
-
简介
AspF9 protein, characterized by a GPI-like anchor, incorporates a phosphoceramide lipid group. The specific anchor position for this protein remains undetermined. AspF9 Protein, Neosartorya fumigata (HEK293, His) is the recombinant AspF9 protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
别名
Probable glycosidase crf1; Crh-like protein 1; crf1; AFUA_1G16190
-
种属
Others
-
表达系统
HEK293
-
标签
C-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8J0P4
-
表达区间
Q20-G370
-
蛋白长度
Full Length of Mature Protein
-
分子量
37.5 kDa.
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AspF9 is a recombinant protein derived from the allergenic fungus Aspergillus fumigatus, which is known to be a significant cause of respiratory allergies and fungal infections, particularly in immunocompromised individuals. This protein is part of a larger family of allergens, and its study has gained attention due to its role in mediating immune responses in sensitive individuals. Research into AspF9 focuses on understanding its structure, function, and interaction with the immune system, as well as its potential as a target for therapeutic interventions, such as allergy immunotherapy. By elucidating the molecular mechanisms behind its allergenic properties, researchers aim to develop more effective diagnostic tools and treatments for individuals suffering from Aspergillus-related allergies and asthma. Furthermore, the recombinant form of AspF9 facilitates the study of its antigenic properties and allows for the evaluation of its potential use in vaccine development. The increasing prevalence of fungal allergies and infections underscores the importance of continuous research into fungal allergens like AspF9, ultimately contributing to better healthcare outcomes for affected populations.
